Decision Aids That Facilitate Elements of Shared Decision Making in Chronic Illnesses: a Systematic Review
Overview
Authors
Affiliations
Background: Shared decision making (SDM) is a patient-centered approach in which clinicians and patients work together to find and choose the best course of action for each patient's particular situation. Six SDM key elements can be identified: situation diagnosis, choice awareness, option clarification, discussion of harms and benefits, deliberation of patient preferences, and making the decision. The International Patient Decision Aid Standards (IPDAS) require that a decision aid (DA) support these key elements. Yet, the extent to which DAs support these six key SDM elements and how this relates to their impact remain unknown.
Methods: We searched bibliographic databases (from inception until November 2017), reference lists of included studies, trial registries, and experts for randomized controlled trials of DAs in patients with cardiovascular, or chronic respiratory conditions or diabetes. Reviewers worked in duplicate and independently selected studies for inclusion, extracted trial, and DA characteristics, and evaluated the quality of each trial.
Results: DAs most commonly clarified options (20 of 20; 100%) and discussed their harms and benefits (18 of 20; 90%; unclear in two DAs); all six elements were clearly supported in 4 DAs (20%). We found no association between the presence of these elements and SDM outcomes.
Conclusions: DAs for selected chronic conditions are mostly designed to transfer information about options and their harms and benefits. The extent to which their support of SDM key elements relates to their impact on SDM outcomes could not be ascertained.
Systematic Review Registration: PROSPERO registration number: CRD42016050320 .
Roldan Munoz S, Mol P, de Vries F, van Dijk P, Hillege H, Postmus D Patient Prefer Adherence. 2025; 19:215-234.
PMID: 39882148 PMC: 11776401. DOI: 10.2147/PPA.S486553.
Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma.
Min Z, Guo Y, Ning L Front Pharmacol. 2024; 15:1490878.
PMID: 39723246 PMC: 11668589. DOI: 10.3389/fphar.2024.1490878.
Fallon L, Lau A, Ciccia D, Duckworth T, Pereira C, Kopp E Health Psychol Behav Med. 2024; 12(1):2383469.
PMID: 39100426 PMC: 11295683. DOI: 10.1080/21642850.2024.2383469.
Physician preferences for an electronic lung cancer screening decision aid.
Morgan O, Schnur J, Diefenbach M, Kale M Am J Manag Care. 2024; 30(6 Spec No.):SP445-SP451.
PMID: 38820185 PMC: 11849514. DOI: 10.37765/ajmc.2024.89551.
Sangeorzan I, Antonacci G, Martin A, Grodzinski B, Zipser C, Murphy R JMIR Res Protoc. 2023; 12:e46809.
PMID: 37812472 PMC: 10594151. DOI: 10.2196/46809.